Brind.

Relay Therapeutics underperformed the market (S&P 500) so far this year, based on data from August 8, 2025.

1 report, 1 independent Updated Aug 8
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Relay Therapeutics underperformed the market (S&P 500) so far this year, based on data from August 8, 2025.

Who's involved

What this event is mainly about
Relay Therapeutics

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • ZacksRelay Therapeutics, Inc. (RLAY) Reports Q2 Loss, Beats Revenue Estimates Relay Therapeutics, Inc. (RLAY) came out with a quarterly loss of $0.41 per share versus the Zacks Consensus Estimate of a los